HBV-IN-25 is a good potency, orally active novel HBV cccDNA reducer. HBV-IN-25 has anti-HBeAg potency and anti-HBV activity with IC50 values of 0.58 µM and 1.15 µM, respectively. HBV-IN-25 has good aqueous solubility (LYSA>452 µg/mL) and good PK property with no cellular toxicity[1].
Molecular Weight:
343.76
CAS Number:
[2161364-69-6]
Formula:
C18H14ClNO4
Target:
HBV
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
